Anzeige
Novara — A Smarter Way to Access Global Markets
Markets-Desk·im Tagesverlauf aktualisiert

Aktien

Börsennachrichten von SIX und SMI, DAX und ATX sowie zu europäischen Aktien – und den globalen Bewegungen dahinter.

Holcim Shares Extend Decline Despite Stronger 2026 Outlook and Earnings
AktienArtikel

Holcim Shares Extend Decline Despite Stronger 2026 Outlook and Earnings

The Swiss building materials group's stock fell 3.5 percent over the week, mirroring broader sector weakness driven by energy costs and high interest rates.

Marktredaktion · 2 Oct 2026
Zurich Insurance Shares Face Declines Amid Broader Market Pressures
AktienArtikel

Zurich Insurance Shares Face Declines Amid Broader Market Pressures

Zurich Insurance shares head toward a fifth consecutive daily loss, reflecting a wider downturn across Swiss and global financial equities.

Marktredaktion · 2 Oct 2026
Julius Baer Launches CHF 600 Million Share Buyback and Updates Capital Policy
AktienArtikel

Julius Baer Launches CHF 600 Million Share Buyback and Updates Capital Policy

The Swiss wealth management group announced a share buyback program of up to CHF 600 million alongside a revised capital distribution policy targeting a CET1 ratio of 15%.

Marktredaktion · 2 Oct 2026
Frankfurt Stocks Close: DAX Slips Below 25,000 Points as 200-Day Moving Average Holds
AktienArtikel

Frankfurt Stocks Close: DAX Slips Below 25,000 Points as 200-Day Moving Average Holds

The German DAX fell 1.03% to close below 25,000 points on Thursday, finding temporary support at its 200-day moving average amid pressure from high oil prices, rising bond yields, and weak US markets.

Marktredaktion · 2 Oct 2026
DAX Closes Lower as Inflation Concerns Offset Positive US Data
AktienArtikel

DAX Closes Lower as Inflation Concerns Offset Positive US Data

Germany's DAX index dropped 0.79 percent on Wednesday, finishing a weak September in negative territory as persistent domestic inflation overshadowed favorable US economic reports.

Marktredaktion · 1 Oct 2026
JPMorgan Buys Into Struggling Swiss Biotech Kuros Despite 34% Year-to-Date Slide
AktienArtikel

JPMorgan Buys Into Struggling Swiss Biotech Kuros Despite 34% Year-to-Date Slide

Wall Street giant expands stake to over 5% in Kuros Biosciences as stock trails 2024's top Swiss performer. UBS also flags Swiss names among its top European tactical picks.

Marktredaktion · 30 Sept 2026
BMW Unveils Major Restructuring, Targets 8-10% ROE by Early 2030s
AktienArtikel

BMW Unveils Major Restructuring, Targets 8-10% ROE by Early 2030s

BMW announced a broad corporate overhaul on Wednesday, including 8,000 job cuts in Munich and a localized product strategy, aiming to restore profitability after a tough period.

Marktredaktion · 30 Sept 2026
EuroStoxx 50 climbs 0.3% as investors stay upbeat amid oil and bond yields
AktienArtikel

EuroStoxx 50 climbs 0.3% as investors stay upbeat amid oil and bond yields

The EuroStoxx 50 rose to 6,320.26 points, led by a 4.2% gain in ASML, while Swiss and UK benchmarks showed mixed moves. Analysts cite optimism on Middle‑East de‑escalation and tech growth.

Marktredaktion · 30 Sept 2026
DocMorris shares rise 10% as target raised, Redcare lagging
AktienArtikel

DocMorris shares rise 10% as target raised, Redcare lagging

DocMorris stock has doubled year‑to‑date after a 10% jump, with Research Partners lifting its price target to CHF 14.60. Analyst compares it with slower‑gaining rival Redcare Pharmacy.

Marktredaktion · 30 Sept 2026
DAX slips 0.13% to 25,374 as US weakness drags German shares
AktienArtikel

DAX slips 0.13% to 25,374 as US weakness drags German shares

The German DAX closed at 25,374.42 points, down 0.13%, after late‑day losses tied to weak US markets, rising oil and gold prices and concerns over AI sector funding.

Marktredaktion · 29 Sept 2026
Calida lifts dividend and launches 2% share buyback, but analysts stay cautious
AktienArtikel

Calida lifts dividend and launches 2% share buyback, but analysts stay cautious

Swiss apparel group Calida announced a dividend payout increase to 40‑60% of adjusted earnings and a share repurchase of up to 2% of capital. Analysts say the moves improve returns but urge faster brand investment.

Marktredaktion · 28 Sept 2026
Roche's Pharma Day Targets Fail to Win Over Investors
AktienArtikel

Roche's Pharma Day Targets Fail to Win Over Investors

The Swiss drugmaker unveiled ambitious R&D goals and cost-cutting plans, but shares slipped as investors remained unimpressed with the outlook.

Marktredaktion · 28 Sept 2026
European stocks stay flat as Iran tensions lift oil, bond yields and hit tech shares
AktienArtikel

European stocks stay flat as Iran tensions lift oil, bond yields and hit tech shares

The Swiss Market Index edged up 0.06% while the DAX and EuroStoxx50 were unchanged; Brent rose to $108 and 10‑year German yields hit 3.65% amid geopolitical risk and AI concerns.

Marktredaktion · 28 Sept 2026
Helvetia Introduces VivaFlex for Flexible Private Pensioning
AktienArtikel

Helvetia Introduces VivaFlex for Flexible Private Pensioning

Swiss insurer Helvetia launches VivaFlex, a new life insurance product designed to adapt to evolving life stages, including part-time work and career transitions.

Marktredaktion · 28 Sept 2026
Roche pushes aggressive pipeline expansion at Pharma Day, cites AI and new "Bar" criteria
AktienArtikel

Roche pushes aggressive pipeline expansion at Pharma Day, cites AI and new "Bar" criteria

Roche outlined a goal of up to 20 new drugs by 2030, introduced a stricter "Bar" framework for candidate selection and highlighted artificial‑intelligence integration across research, aiming for >30 bn CHF sales from top prospects.

Marktredaktion · 28 Sept 2026
Bernstein Names Sonova, Alcon Top European Medtech Picks for H2
AktienArtikel

Bernstein Names Sonova, Alcon Top European Medtech Picks for H2

The firm highlighted Sonova as its short-term top pick and Alcon as the preferred long-term play, citing strong fundamentals in hearing aids and ophthalmology.

Marktredaktion · 25 Sept 2026
SMI holds steady; UBS, Givaudan in demand; Semiconductor stocks rise; Nestlé underperforms
AktienArtikel

SMI holds steady; UBS, Givaudan in demand; Semiconductor stocks rise; Nestlé underperforms

Swiss stock market shows slight gains; UBS and Givaudan see increased interest; semiconductor stocks rise; Nestlé underperforms; new ratings and price targets for Swiss stocks

Marktredaktion · 25 Sept 2026
SMI Holds Steady; ABB and UBS Rise, Nestlé Struggles
AktienArtikel

SMI Holds Steady; ABB and UBS Rise, Nestlé Struggles

Swiss stock market shows resilience, with ABB and UBS gaining while Nestlé lags. Oil prices and bond yields remain key market drivers.

Marktredaktion · 25 Sept 2026